ExlService Holdings, Inc. EXLS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, ExlService Holdings, Inc. reported revenue across 3 business segments; the largest, Insurance, was $830M, 39.8% of the filed sum (+8.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Insurance$830M39.8%+8.2% yoy
- Banking Capital Markets And Diversified Industries$724M34.7%+13.3% yoy
- Healthcare And Life Sciences$534M25.6%+23.6% yoy
Members sum to the consolidated $2.09B for this period.
- Data And AI Led Services$1.16B55.3%+17.9% yoy
- Digital Operations Service$932M44.7%+8.6% yoy
Members sum to the consolidated $2.09B for this period.
- North America$1.73B82.7%+14.0% yoy
- The United Kingdom And Europe$307M14.7%+12.8% yoy
- Rest of world$54.8M2.6%+5.3% yoy
Members sum to the consolidated $2.09B for this period.
- Insurance$234M39.3%+15.0% yoy
- Banking Capital Markets And Diversified Industries$203M34.1%+11.7% yoy
- Healthcare And Life Sciences$158M26.6%+22.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.